MicroPort Endovascular Medtech Obtains Regulatory Approval for Detachable Fibered Embolic Coil

Stock News
Mar 13

Shanghai Microport Endovascular Medtech (Group) Co., Ltd. (688016.SH) has announced that its subsidiary, Shanghai Hongmai Medical Technology Co., Ltd., recently received a medical device registration certificate from the National Medical Products Administration for a detachable fibered embolic coil. The HawkMaster™/LongYuan™ detachable fibered embolic coil is the company's second coil embolization product approved for market launch, following the HawkNest™/YingChao™ fibered embolic coil. The introduction of this product further enriches the company's portfolio in the peripheral artery field and enhances its product offerings in the peripheral vascular interventional therapy sector.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10